home / scout

Targets — browse / sort / filter (view)

One row per human protein target with names + key evidence. Click column headers to SORT; use the facets to FILTER (tier, activation pair, known aptamer, EV-Map). UniProt IDs link to the source. Default sort is evidence_priority — a DETERMINISTIC, reproducible score computed from harvested evidence (structure / disease / predicted-surface / EV-detection). Filter has_structure=1 for the core set: targets with a reported 3D structure (the requirement the Kd layer is built around).

Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target

id
UniProt accession (human). Links to uniprot.org.
gene_symbol
Gene symbol (e.g. ITGB3).
protein_name
Protein name (UniProt).
tier
Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
has_structure
1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
evidence_priority
DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
has_activation_state_pdb_pair
1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
in_cev_map
Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
has_known_aptamer
1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
opentargets_top_disease_score
Open Targets association score (0-1).
aptamer_count_pubmed
Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
aptamer_pmids
The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
surface_class
PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.

2,977 rows where has_cryoEM = 0, has_known_aptamer = 0 and tier = "Tier 1.5" sorted by evidence_priority descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: pdb_count_total

surface_class 5

  • B_cargo 1,593
  • unknown 667
  • A_surface 385
  • A2_pm_peripheral 173
  • A_assoc 159

in_cev_map 2

  • 0 1,865
  • 1 1,112

has_structure 2

  • 0 2,201
  • 1 776

tier 1

  • Tier 1.5 · 2,977 ✖

has_known_aptamer 1

  • - · 2,977 ✖

has_cryoEM 1

  • - · 2,977 ✖

has_activation_state_pdb_pair 1

  • 0 2,977
id gene_symbol protein_name tier evidence_priority ▲ has_structure surface_class pdb_count_total alphafold_mean_pLDDT has_cryoEM has_activation_state_pdb_pair activation_state_pdb_active activation_state_pdb_inactive has_known_aptamer aptamer_count_pubmed aptamer_pmids in_cev_map opentargets_top_disease_name opentargets_top_disease_score
P51795 CLCN5 H(+)/Cl(-) exchange transporter 5 Tier 1.5 0.955 1 A_surface 2 80.62 0 0     0 0   1 Dent disease type 1 0.850724240157394
P25189 MPZ Myelin protein P0 Tier 1.5 0.951 1 A_surface 2 81.69 0 0     0 0   1 Charcot-Marie-Tooth disease type 1B 0.8377022197539885
P13473 LAMP2 Lysosome-associated membrane glycoprotein 2 Tier 1.5 0.948 1 A_surface 2 83.19 0 0     0 0   1 Glycogen Storage Disease Type 2b 0.8273010649608126
O94856 NFASC Neurofascin Tier 1.5 0.933 1 A_surface 2 76.31 0 0     0 0   1 neurodevelopmental disorder with central and peripheral motor dysfunction 0.7782432580663833
Q15746 MYLK Myosin light chain kinase, smooth muscle Tier 1.5 0.93 1 A_surface 7 65.88 0 0     0 0   1 aortic aneurysm, familial thoracic 7 0.7659842793171938
Q02413 DSG1 Desmoglein-1 Tier 1.5 0.92 1 A_surface 1 62.06 0 0     0 0   1 severe dermatitis-multiple allergies-metabolic wasting syndrome 0.7335328506238418
Q13555 CAMK2G Calcium/calmodulin-dependent protein kinase type II subunit gamma Tier 1.5 0.891 1 A_surface 2 78.38 0 0     0 0   1 intellectual developmental disorder 59 0.6354497016986491
Q92956 TNFRSF14 Tumor necrosis factor receptor superfamily member 14 Tier 1.5 0.879 1 A_surface 8 79.94 0 0     0 0   1 diffuse large B-cell lymphoma 0.5983171413833771
P01597 IGKV1-39 Immunoglobulin kappa variable 1-39 Tier 1.5 0.876 1 A_surface 2 90.5 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01764 IGHV3-23 Immunoglobulin heavy variable 3-23 Tier 1.5 0.876 1 A_surface 6 91.0 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P23083 IGHV1-2 Immunoglobulin heavy variable 1-2 Tier 1.5 0.876 1 A_surface 1 91.75 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P01593 IGKV1D-33 Immunoglobulin kappa variable 1D-33 Tier 1.5 0.876 1 A_surface 6 90.88 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
P06312 IGKV4-1 Immunoglobulin kappa variable 4-1 Tier 1.5 0.876 1 A_surface 10 90.62 0 0     0 0   1 cutaneous Leishmaniasis 0.5868213846274001
Q96D96 HVCN1 Voltage-gated hydrogen channel 1 Tier 1.5 0.865 1 A_surface 2 69.75 0 0     0 0   1 Joubert syndrome 0.5504227269701596
Q9P1W8 SIRPG Signal-regulatory protein gamma Tier 1.5 0.864 1 A_surface 2 85.5 0 0     0 0   1 type 1 diabetes mellitus 0.5457344827318543
O15155 BET1 BET1 homolog Tier 1.5 0.864 1 A_surface 1 83.06 0 0     0 0   1 neurodegenerative disease 0.5468418315282804
P34741 SDC2 Syndecan-2 Tier 1.5 0.863 1 A_surface 1 60.84 0 0     0 0   1 COVID-19 0.5422254875204983
O00161 SNAP23 Synaptosomal-associated protein 23 Tier 1.5 0.859 1 A_surface 2 82.12 0 0     0 0   1 neurodegenerative disease 0.5288361677964304
P54756 EPHA5 Ephrin type-A receptor 5 Tier 1.5 0.858 1 A_surface 2 79.38 0 0     0 0   1 neurodegenerative disease 0.5261379875719714
Q9HCM2 PLXNA4 Plexin-A4 Tier 1.5 0.856 1 A_surface 1 83.06 0 0     0 0   1 neurodegenerative disease 0.518371001420808
P02462 COL4A1 Collagen alpha-1(IV) chain Tier 1.5 0.854 1 A_assoc 4 48.47 0 0     0 0   1 brain small vessel disease 1 with or without ocular anomalies 0.84655287380359
P15814 IGLL1 Immunoglobulin lambda-like polypeptide 1 Tier 1.5 0.85 1 A_surface 3 75.06 0 0     0 0   1 isolated agammaglobulinemia 0.4996673834185043
P18084 ITGB5 Integrin beta-5 Tier 1.5 0.846 1 A_surface 3 82.19 0 0     0 0   1 migraine disorder 0.48652455084344876
P22105 TNXB Tenascin-X Tier 1.5 0.837 1 A_assoc 3 87.81 0 0     0 0   1 Ehlers-Danlos syndrome due to tenascin-X deficiency 0.7916412481554758
A1L3X0 ELOVL7 Very long chain fatty acid elongase 7 Tier 1.5 0.828 1 A_surface 1 89.75 0 0     0 0   1 substance-related disorder 0.4271436896798171
Q92854 SEMA4D Semaphorin-4D Tier 1.5 0.828 1 A_surface 2 80.81 0 0     0 0   1 skin aging 0.4259843235238637
P20702 ITGAX Integrin alpha-X Tier 1.5 0.825 1 A_surface 9 88.0 0 0     0 0   1 neurodegenerative disease 0.41708750879240836
P08572 COL4A2 Collagen alpha-2(IV) chain Tier 1.5 0.819 1 A_assoc 4 47.25 0 0     0 0   1 porencephaly 2 0.7294975109351518
P35080 PFN2 Profilin-2 Tier 1.5 0.817 1 A_surface 1 95.5 0 0     0 0   1 smoking initiation 0.38873499449725424
Q08554 DSC1 Desmocollin-1 Tier 1.5 0.81 1 A_surface 2 76.75 0 0     0 0   1 atopic eczema 0.3674657640592667
O95255 ABCC6 ATP-binding cassette sub-family C member 6 Tier 1.5 0.809 1 A_surface 4 80.94 0 0     0 0   0 Pseudoxanthoma elasticum 0.864631668818611
O75144 ICOSLG ICOS ligand Tier 1.5 0.803 1 A_surface 2 82.56 0 0     0 0   1 immunodeficiency 119 0.34184658238916177
P30968 GNRHR Gonadotropin-releasing hormone receptor Tier 1.5 0.799 1 A_surface 1 84.19 0 0     0 0   0 hypogonadotropic hypogonadism 0.83100005285263
O75015 FCGR3B Low affinity immunoglobulin gamma Fc region receptor III-B Tier 1.5 0.795 1 A_surface 6 88.62 0 0     0 0   1 Takayasu arteritis 0.3170299762085396
P29400 COL4A5 Collagen alpha-5(IV) chain Tier 1.5 0.794 1 A2_pm_peripheral 2 48.12 0 0     0 0   1 X-linked Alport syndrome 0.8472963899466404
Q14315 FLNC Filamin-C Tier 1.5 0.791 1 A2_pm_peripheral 14 75.06 0 0     0 0   1 hypertrophic cardiomyopathy 26 0.8363192336142512
O43525 KCNQ3 Potassium voltage-gated channel subfamily KQT member 3 Tier 1.5 0.789 1 A_surface 1 56.72 0 0     0 0   0 Benign familial neonatal seizures 0.7961763561533409
P37023 ACVRL1 Activin receptor type-1-like Tier 1.5 0.789 1 A_surface 7 82.0 0 0     0 0   0 telangiectasia, hereditary hemorrhagic, type 2 0.7951167515831324
Q13698 CACNA1S Voltage-dependent L-type calcium channel subunit alpha-1S Tier 1.5 0.786 1 A_surface 2 71.81 0 0     0 0   0 hypokalemic periodic paralysis, type 1 0.7869997029542154
Q9Y6C2 EMILIN1 EMILIN-1 Tier 1.5 0.786 1 A_assoc 2 62.91 0 0     0 0   1 arterial tortuosity-bone fragility syndrome 0.6185329512431467
P49767 VEGFC Vascular endothelial growth factor C Tier 1.5 0.785 1 A_assoc 4 73.19 0 0     0 0   1 Milroy disease 0.6170524106764851
O75396 SEC22B Vesicle-trafficking protein SEC22b Tier 1.5 0.783 1 A_surface 5 83.5 0 0     0 0   1 inflammatory bowel disease 0.27585917531110155
O95630 STAMBP STAM-binding protein Tier 1.5 0.782 1 A2_pm_peripheral 5 84.0 0 0     0 0   1 microcephaly-capillary malformation syndrome 0.8060251236043802
Q8TDI8 TMC1 Transmembrane channel-like protein 1 Tier 1.5 0.781 1 A_surface 1 76.88 0 0     0 0   0 autosomal recessive nonsyndromic hearing loss 7 0.7694318181814068
P12814 ACTN1 Alpha-actinin-1 Tier 1.5 0.777 1 A2_pm_peripheral 4 85.25 0 0     0 0   1 platelet-type bleeding disorder 15 0.7887662502912471
Q9NUN7 ACER3 Alkaline ceramidase 3 Tier 1.5 0.777 1 A_surface 2 93.19 0 0     0 0   0 alkaline ceramidase 3 deficiency 0.7575827142824458
Q12983 BNIP3 BCL2/adenovirus E1B 19 kDa protein-interacting protein 3 Tier 1.5 0.773 1 A_surface 3 63.62 0 0     0 0   1 hidradenitis 0.24436077603455422
Q9Y6J6 KCNE2 Potassium voltage-gated channel subfamily E member 2 Tier 1.5 0.772 1 A_surface 1 78.25 0 0     0 0   0 Romano-Ward syndrome 0.739531738338193
O14523 C2CD2L Phospholipid transfer protein C2CD2L Tier 1.5 0.772 1 A_surface 1 63.94 0 0     0 0   1 neurodegenerative disease 0.23848230499510428
O43914 TYROBP TYRO protein tyrosine kinase-binding protein Tier 1.5 0.77 1 A_surface 5 64.62 0 0     0 0   0 Nasu-Hakola disease 0.7323368313860329

Next page

Advanced export

JSON shape: default, array, newline-delimited

CSV options:

CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
 -- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
 -- Transparent weights over harvested evidence: structure 0.35, disease importance
 -- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
 -- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
 -- are predictions/detections, NOT measured EV-surface exposure.
 ROUND(
   0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
              WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
 + 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
 + 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
 + 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
 , 3) AS evidence_priority,
 (CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
 sc.surface_class,
 f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
 f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
 f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
 f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;
Powered by Datasette · Queries took 954.123ms · Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target